As Neuren Rises, CSL Shares Down Amid Trump’s Tariff Warnings
This week, the biotech market saw some drama. Neuren Pharmaceuticals’ stock rose by nearly 1%. At the same time, CSL shares dropped again, falling to an 18-month low. What caused this split? A warning from U.S. President Donald Trump. President Trump plans to add tariffs on foreign-made medicines to boost U.S. drug production. That includes…